
THE UTILITY OF WHOLE EXOME SEQUENCING
IN DIAGNOSING PEDIATRIC NEUROLOGICAL DISORDERS Muthaffar OY *Corresponding Author: Osama Y. Muthaffar, M.D., Department of Pediatrics, King Abdulaziz
University, Jeddah, PO Box 80215, Jeddah 21589, Kingdom of Saudi Arabia. Tel.: +96-12-640-1000
(ext. 20208). Fax: 996-12-640-3975. E-mail: oymuthaffar@kau.edu.sa; osamam@hotmail.com page: 17 download article in pdf format
|
Abstract
Pediatric neurological disorders have a wide spectrum
of clinical presentations and can be challenging to
diagnose. Whole exome sequencing (WES) is increasingly
becoming an integral diagnostic tool in medicine. It is
cost-effective and has high diagnostic yield, especially in
consanguineous populations. This study aims to review
WES results and its value in diagnosing neurological disorders.
A retrospective chart review was performed for WES
results between the period of January 2018 to November
2019. Whole exome sequencing was requested for children
with unexplained neurological signs and symptoms such
as epilepsy, developmental delay, visual impairment, spasticity,
hypotonia and magnetic resonance imaging (MRI)
brain changes. It was conducted for children in a pediatric
neurology clinic of a tertiary center at Jeddah, Saudi Arabia.
Twenty-six children with undiagnosed neurological
conditions were identified and underwent WES diagnosis.
Nineteen patients (73.0%) of the cohort were diagnosed
with pathogenic variants, likely pathogenic variants or
variants of unknown significance (VUS). Consanguinity
was positive in 18 families of the cohort (69.0%). Seven
patients showed homozygous mutations. Five patients had
heterozygous mutations. There were six patients with VUS
and six patients had negative WES results. Whole exome
sequencing showed a high diagnostic rate in this group of
children with variable neurological disorders.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|